Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 17/20 | 0.47 |
| ▸ | MAOB | P27338 | 3/20 | 0.46 |
| ▸ | MAOA | P21397 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.46 |
| ▸ | CALML3 | P27482 | 1/20 | 0.46 |
| ▸ | SDHA | P31040 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6513194 | 0.86 | F10 (0.44) | F10MAOBMAOALMNAPTGS1 | |
| SCHEMBL6513198 | 0.86 | F10 (0.44) | F10MAOBMAOALMNAPTGS1 | |
| SCHEMBL78782 | 0.86 | F10 (0.67) | F10 | |
| SCHEMBL6508870 | 0.86 | MAOB (0.43) | F10MAOBMAOALMNAPTGS1 | |
| SCHEMBL6508866 | 0.86 | MAOB (0.43) | F10MAOBMAOALMNAPTGS1 | |
| SCHEMBL7814509 | 0.83 | MAOA (0.55) | MAOBMAOACALML3 | |
| SCHEMBL79733 | 0.81 | F10 (0.50) | F10MAOBMAOA | |
| SCHEMBL6511456 | 0.81 | F10 (0.44) | F10MAOBMAOALMNAPTGS1 | |
| SCHEMBL6511460 | 0.81 | F10 (0.44) | F10MAOBMAOALMNAPTGS1 | |
| Hydrochloric Acid SCHEMBL8124261 | 0.80 | F10 (0.49) | F10MAOBMAOACALML3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1045709-B1 | METHOD AND DEVICE FOR IN-SITU FORMULATION OF A MEDICINAL SOLUTION FOR PARENTERAL APPLICATION | BAYER AG (DE) | 2003-12-03 | — | — | EP | disclosed |
| US-6540715-B1 | Method and device for in-situ formulation of a medicinal solution for parenteral application | BAYER AKTIENGESELLSCHAFT (DE) | 2003-04-01 | — | — | US | disclosed |